Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H13ClN2O |
Molecular Weight | 284.74 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C3=CC=CC=C3
InChI
InChIKey=AAOVKJBEBIDNHE-UHFFFAOYSA-N
InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3
Molecular Formula | C16H13ClN2O |
Molecular Weight | 284.74 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:05:32 UTC 2023
by
admin
on
Sat Dec 16 17:05:32 UTC 2023
|
Record UNII |
Q3JTX2Q7TU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000007542
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
FDA ORPHAN DRUG |
384112
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
EPA PESTICIDE CODE |
600069
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
FDA ORPHAN DRUG |
334911
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
FDA ORPHAN DRUG |
518316
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.4
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
LIVERTOX |
NBK548352
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
WHO-VATC |
QN05BA01
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
FDA ORPHAN DRUG |
543516
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
FDA ORPHAN DRUG |
638118
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
24.3
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
FDA ORPHAN DRUG |
382512
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
WHO-ATC |
N05BA01
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
05
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
DEA NO. |
2765
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
NCI_THESAURUS |
C1012
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
FDA ORPHAN DRUG |
61591
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
||
|
NDF-RT |
N0000175694
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1185008
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
m4267
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | Merck Index | ||
|
169897
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
3322
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | RxNorm | ||
|
D003975
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
3057
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
Diazepam
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
DB00829
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
DTXSID4020406
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
852
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
DIAZEPAM
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
SUB07069MIG
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
3364
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
Q3JTX2Q7TU
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
C28982
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
1295
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
439-14-5
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
3016
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
CHEMBL12
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
49575
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
207-122-5
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
100000092362
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
Q3JTX2Q7TU
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
77518
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | |||
|
DIAZEPAM
Created by
admin on Sat Dec 16 17:05:34 UTC 2023 , Edited by admin on Sat Dec 16 17:05:34 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder; odourless or almost odourless. Solubility: Very slightly soluble in water; soluble in ethanol (~750 g/l) TS. Category: Tranquillizer. Storage: Diazepam should be kept in a well-closed container, protected from light. Definition: Diazepam contains not less than 99.0% and not more than 101.0% of C16H13ClN2O, calculated with reference to the dried substance. |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BINDER->LIGAND |
BINDING
|
||
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE | |||
|
METABOLITE ACTIVE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT | |||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PARENT | |||
|
METABOLITE TOXIC -> PARENT |
Metabolite produces adverse autonomic nervous symptoms in man.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
pKa | CHEMICAL |
|
||||
Volume of Distribution | PHARMACOKINETIC |
|
||||
Tmax | PHARMACOKINETIC |
|
IV: 8 minutes |
|
||
PROTEIN BINDING | PHARMACOKINETIC |
|
||||
Biological Half-life | PHARMACOKINETIC |
|
IV: 15-21 HOURS (CHILD 2-12 YEARS) |
|||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
SEDATION, ENDOSCOPIC PROCEDURE: 20 mg IV IMMEDIATELY PRIOR TO PROCEDURE |
|
||
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
|
|||
BIOAVAILABILTY | PHARMACOKINETIC |
|
|
|||